Veeva operates a CRM platform for the life sciences industry, built on salesforce.com. TTM revenue growth of 26% and 41.4% free cash flow margin are exceptional. Stock price is massively overvalued.
from crm - BingNews https://ift.tt/2LlKTQr
September 05, 2019 at 03:19PM
No comments:
Post a Comment